Erratum to: Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer

Affiliations

• ¹ Breast Surgical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
• ² Division of Pathology, Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan.
• ³ Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan.
• ⁴ Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan.
• ⁵ Department of Surgery, Breast Oncology, NHO Osaka National Hospital, Osaka, Japan.
• ⁶ Department of Breast and Endocrine Surgery, Graduate School of Medical Science Kumamoto University, Kumamoto, Japan.
• ⁷ Breast Surgery, Hokkaido University Hospital, Kita 14, Nishi 5, Kita-ku, Sapporo, 060-8648, Japan.
• ⁸ Department of Breast and Endocrine Surgery, Kumamoto City Hospital, Kumamoto, Japan.
• ⁹ Kumamoto Shinto General Hospital, Kumamoto, Japan.
• ¹⁰ Department of Breast Surgery, NHO Hokkaido Cancer Center, Sapporo, Japan.
• ¹¹ Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
• ¹² Breast Surgery, Hokkaido University Hospital, Kita 14, Nishi 5, Kita-ku, Sapporo, 060-8648, Japan. [email protected].